Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
about
The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infectionsMRSA--what is it, and how do we deal with the problem?In vivo characterization of the peptide deformylase inhibitor LBM415 in murine infection models.Complete heart block in a patient with acute lymphoblastic leukaemia: teicoplanin as a possible cause and review of literature.Linezolid: a promising option in the treatment of Gram-positives.
P2860
Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
@ast
Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
@en
type
label
Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
@ast
Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
@en
prefLabel
Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
@ast
Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
@en
P2860
P356
P1476
Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.
@en
P2093
Deirbhile Keady
Milind Khare
P2860
P304
P356
10.1517/14656566.4.2.165
P407
P577
2003-02-01T00:00:00Z